RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth

American Journal of Pathology

Volumn 171, Issue 3, 2007, Pages 947-961

  Riuzzi, Francesca ^a   Sorci, Guglielmo ^a   Donato, Rosario ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE P38; RAC1 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL MUTANT; CELL PROLIFERATION; CELL VOLUME; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENETIC TRANSFECTION; GLYCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TUMOR GROWTH; WILD TYPE;

EID: 34548859509     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070049     Document Type: Article

References (69)

1. Andrés V, Walsh K: Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 1996, 132:657-666
2. Arnold HH, Winter B: Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet Dev 1998, 8:539-544
3. Chargé SB, Rudnicki MA: Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004, 84:209-238
4. Buckingham M: Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev 2006, 16:525-532
5. Lassar AB, Skapek SX, Novitch B: Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 1994, 6:788-794
6. Florini JR, Ewton DZ, Coolican SA: Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 1996, 17:481-517
7. Langen RC, Schols AM, Kelders MC, Wouters EF, Janssen-Heininger YM: Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB. FASEB J 2001, 15:1169-1180
8. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadurm R: Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003, 162:1135-11347
9. Sorci G, Agneletti AL, Riuzzi F, Marchetti C, Donato R: S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol 2003, 23:4870-4881
10. Kang JS, Yi MJ, Zhang W, Feinleib JL, Cole F, Krauss RS: Netrins and neogenin promote myotube formation. J Cell Biol 2004, 167:493-404
11. Sorci G, Riuzzi F, Arcuri C, Giambanco I, Donato R: Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol Cell Biol 2004, 24:4880-4894
12. Bennett AM, Tonks NK: Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997, 278:1288-1291
13. Winter B, Arnold H-H: Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J Cell Sci 2000, 113:4211-4220
14. Perry RL, Parker MH, Rudnicki MA: Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol Cell 2001, 8:291-301
15. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JYJ, Puri PL: p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 2000, 20:3951-3964
16. Guttridge DC: Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 2004, 7:443-450
17. Lluis F, Perdiguero E, Nebreda AR, Munoz-Canoves P: Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol 2006, 16:36-44
18. Palacios D, Puri PL: The epigenetic network regulating muscle development and regeneration. J Cell Physiol 2006, 207:1-11
19. Schmidt AM, Yan SD, Yan SF, Stern D: The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000, 1498:99-111
20. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T, Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, Stern D, Schmidt AM: RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691
21. Huttunen HJ, Kuja-Panula J, Rauvala H: Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 2002, 277:38635-38646
22. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H: Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through RAGE activation. J Biol Chem 2000, 275:40096-40105
23. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM: Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. Cell 1999, 97:889-901
24. Taguchi A, Blood DC, del Toro G, Canet A, Lee DC, Qu W, Tanji N, Lu Y, Lalla E, Fu C, Hofmann MA, Kislinger T, Ingram M, Lu A, Tanaka H, Hori O, Ogawa S, Stern DM, Schmidt AM: Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360
25. Takada M, Koizumi T, Toyama H, Suzuki Y, Kuroda Y: Differential expression of RAGE in human pancreatic carcinoma cells. Hepatogastroenterology 2001, 48:1577-1578
26. Huttunen HJ, Fages C, Kuja-Panula J, Ridley AJ, Rauvala H: Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002, 62:4805-4811
27. Kuniyasu H, Chihara Y, Kondo H: Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 2003, 104:722-727
28. Riuzzi F, Sorci G, Donato R: The amphoterin/RAGE pair modulates myoblast proliferation, apoptosis, adhesiveness, migration and invasiveness: functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem 2006, 281:8242-8253
29. Stratton MR, Darling J, Pilkington GJ, Lantos PL, Reeves BR, Cooper CS: Characterization of the human cell line TE671. Carcinogenesis 1989, 10:899-905
30. Tapscott SJ, Thayer MJ, Weintraub H: Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 1993, 259:1450-1453
31. Otten AD, Firpo EJ, Gerber AN, Brody LL, Roberts JM, Tapscott SJ: Inactivation of MyoD-mediated expression of p21 in tumor cell lines. Cell Growth Differ 1997, 8:1151-1160
32. Puri PL, Wu Z, Zhang P, Wood LD, Bhakta KS, Han J, Feramisco JR, Karin M, Wang JYJ: Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev 2000, 14:574-584
33. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, Pan YC, Elliston K, Stern D, Shaw A: Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992, 267:14998-15004
34. Huttunen HJ, Fages C, Rauvala H: Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999, 274:19919-19924
35. Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J: Involvement of the MKK6-p38γ cascade in γ-radiation-induced cell cycle arrest. Mol Cell Biol 2000, 20:4543-4552
36. Caron E, Hall A: Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998, 282:1717-1721
37. Raingeaud J, Whitmarsh AJ, Barrett T, Derijard B, Davis RJ: MKK3-and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol 1996, 16:1247-1255
38. Vincent CK, Gualberto A, Patel CV, Walsh K: Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol 1993, 13:1264-1272
39. Gerber AN, Klesert TR, Bergstrom DA, Tapscott SJ: Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev 1997, 11:436-450
40. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825
41. Charoonpatrapong K, Shah R, Robling AG, Alvarez M, Clapp DW, Chen S, Kopp RP, Pavalko FM, Yu J, Bidwell JP: HMGB1 expression and release by bone cells. J Cell Physiol 2006, 207:480-490
42. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991, 139:271-279
43. Ahmadzadeh M, Hussain SF, Faber DL: Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J Immunol 1999, 163:3053-3063
44. Rauvala H, Pihlaskari R: Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem 1987, 262:16625-16635
45. Meriane M, Roux P, Primig M, Fort P, Gauthier-Rouviere C: Critical activities of Rad and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol Biol Cell 2000, 11:2513-2528
46. Meriane M, Charrasse S, Comunale F, Mery A, Fort P, Roux P, Gauthier-Rouviere C: Participation of small GTPases Rac1 and Cdc42Hs in myoblast transformation. Oncogene 2002, 21:2901-2907
47. Mauro A, Ciccarelli C, De Cesaris P, Scoglio A, Bouclé M, Molinaro M, Aquino A, Zani BM: PKCα-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J Cell Sci 2002, 115:3587-3599
48. Charrasse S, Causeret M, Comunale F, Bonet-Kerrache A, Gauthier-Rouviere C: Rho GTPases and cadherin-based cell adhesion in skeletal muscle development. J Muscle Res Cell Motil 2003, 24:309-313
49. Bryan BA, Mitchell DC, Zhao L, Ma W, Stafford LJ, Teng B-B, Liu M: modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT. Mol Cell Biol 2005, 25:11089-11101
50. Zetser A, Gredinger E, Bengal E: p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation: participation of the Mef2c transcription factor. J Biol Chem 1999, 274:5193-5200
51. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP: Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 1995, 92:5451-5455
52. Rao SS, Kohtz DS: Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor β: a role for cyclin D1 in control of myoblast differentiation. J Biol Chem 1995, 270:4093-4100
53. Porrello A, Cerone MA, Coen S, Gurtner A, Fontemaggi G, Cimino L, Piaggio G, Sacchi A, Soddu S: p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol 2000, 151.1295-1304
54. Chen B, He L, Savell VH, Jenkins JJ, Parham DM: Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res 2000, 60:3290-3298
55. Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M: Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol 2006, 176:12-15
56. Krauss RS, Cole F, Gaio U, Takaesu G, Zhang W, Kang J-S: Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact. J Cell Sci 2005, 118:2355-2362
57. Wegorzewska M, Krauss RS, Kang J-S: Overexpression of the immunoglobulin superfamily members CDO and BOC enhances differentiation of human rhabdomyosarcoma cell line RD. Mol Carcinog 2003, 37:1-4
58. Bartling B, Hofmann HS, Weigle B, Silber RE, Simm A: Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 2005, 26:293-301
59. Briata P, Forcales SV, Ponassi M, Corte G, Chen C-Y, Karin M, Puri PL, Gherzi R: p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell 2005, 20:891-903
60. 1/S through a mechanism requiring p38/ERK. J Biol Chem 1997, 272:13229-13235
61. Haq R, Brenton JD, Takahashi M, Finan D, Finkielsztein A, Damaraju S, Rottapel R, Zanke B: Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res 2002, 62:5076-5082
62. 1 cell-cycle control and cancer. Nature 2004, 432:298-306
63. Zhang J, Hu S, Schofield DE, Sorensen PH, Triche TJ: Selective usage of D-type cyclins by Ewing's tumors and rhabdomyosarcomas. Cancer Res 2004, 64:6026-6034
64. Fu M, Wang C, Rao M, Wu X, Bouras T, Zhang X, Li Z, Jiao X, Yang J, Li A, Perkins ND, Thimmapaya B, Kung AL, Munoz A, Giordano A, Lisanti M, Pestell RG: Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem 2005, 280:29728-29742
65. Albanese C, Wu K, D'Amico M, Jarrett C, Joyce D, Hughes J, Hulit J, Sakamaki T, Fu M, Ben-Ze'ev A, Bromberg JF, Lamberti C, Verma U, Gaynor RB, Byers SW, Pestell RG: IKKα regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell 2003, 14:585-599
66. 1 phase. Biochem J 1997, 326:61-68
67. Lee J, Hong F, Kwon S, Kim SS, Kim DO, Kang HS, Lee SJ, Ha J, Kim SS: Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem Biophys Res Commun 2002, 298:765-771
68. Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P, Baeza-Raja B, Jardi M, Bosch-Comas A, Esteller M, Caelles C, Serrano AL, Wagner EF, Munoz-Canoves P: Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferation. EMBO J 2007, 26:1245-1256
69. Barr FG: Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene 2001, 20:5736-5746